| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/14/2005 | CN1666763A Dripping pills of six Ingredients with Rehmanniae |
| 09/14/2005 | CN1666758A Healthy toxin-expelling edible bamboo charcoal |
| 09/14/2005 | CN1666756A Pain-relieving navel-applied paste |
| 09/14/2005 | CN1666754A Semi-solid oral formulation of Chinese medicine |
| 09/14/2005 | CN1666748A Oral formulation of adetphos |
| 09/14/2005 | CN1666742A Combination therapy to treat hepatitis b virus |
| 09/14/2005 | CN1666737A Application of citric acid solution in preparation of antiphlogistic drug |
| 09/14/2005 | CN1218943C 4-pyrimidine-N-acyl-L-phenylalanines compound |
| 09/14/2005 | CN1218940C Nitric oxide synthase inhibitors |
| 09/14/2005 | CN1218750C Recombinant hepatitis B BCG vaccine combined vaccine for intradermal injection and its preparation method |
| 09/14/2005 | CN1218745C Health food for protecting liver and adjusting blood fat and method for preparing the same |
| 09/14/2005 | CN1218742C Medicine for treating acute bacillary dysentery and acute enteritis |
| 09/14/2005 | CN1218741C Fingered citron particles for stomach ailment and its preparing method |
| 09/14/2005 | CN1218734C Health products for improving functions of stomach intestine |
| 09/14/2005 | CN1218714C Kidney asthenia treating medicine and its prepn process |
| 09/14/2005 | CN1218706C Hepatitis B treating pill |
| 09/14/2005 | CN1218698C Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 09/14/2005 | CN1218693C Adhesive film agent of Chinese traditional medicine and its preparing method |
| 09/14/2005 | CN1218692C Film coating |
| 09/13/2005 | US6943253 6-phenylpyrrolopyrimidinedione derivatives |
| 09/13/2005 | US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl] |
| 09/13/2005 | US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof |
| 09/13/2005 | US6943190 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
| 09/13/2005 | US6943182 Cyclopentabenzofuran derivatives and their use |
| 09/13/2005 | US6943180 Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 09/13/2005 | US6943176 Heterocyclic derivatives |
| 09/13/2005 | US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. |
| 09/13/2005 | US6943171 For therapy of urological, vascular or pulmonary disorders |
| 09/13/2005 | US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds |
| 09/13/2005 | US6943146 Control cell proliferation, cell differentiation; culture product |
| 09/13/2005 | US6942849 Incorporation of exogenous lactic bacteria into the oral microflora |
| 09/13/2005 | CA2371587C Piperidine derivatives useful as ccr5 antagonists |
| 09/13/2005 | CA2371583C Piperazine derivatives useful as ccr5 antagonists |
| 09/13/2005 | CA2323863C Methods and compositions for treating and preventing mucositis |
| 09/13/2005 | CA2279276C Arylsulfonylamino hydroxamic acid derivatives |
| 09/09/2005 | WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha |
| 09/09/2005 | WO2005082905A1 Bicyclic heterocyclic compound |
| 09/09/2005 | WO2005082887A1 Pyrimidine derivative |
| 09/09/2005 | WO2005082874A1 Novel benzothiazepine and benzothiepine compounds |
| 09/09/2005 | WO2005082865A1 Fused bicyclic pyrimidine derivative |
| 09/09/2005 | WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 09/09/2005 | WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 09/09/2005 | WO2005082402A1 Preventive/therapeutic agent for organ fibrosis |
| 09/09/2005 | WO2005082377A1 INHIBITOR FOR LOWERING IN THE ACTIVITY OF ANTIHUMAN TNF-α ANTIBODY |
| 09/09/2005 | WO2005082373A1 Medicinal eudistomin derivative composition |
| 09/09/2005 | WO2005081613A2 Pharmaceutical compositions of peptides secreted by the venom glands of snakes |
| 09/09/2005 | WO2004064542A8 Composition for oral administration containing capsaicinoids |
| 09/09/2005 | WO2004060081A8 A method of improving nutrient utilisation by a mammal and a composition for use therein |
| 09/09/2005 | CA2557541A1 Pyrimidine derivatives |
| 09/09/2005 | CA2556914A1 Amines and amides for the treatment of diseases |
| 09/09/2005 | CA2556756A1 Compositions comprising prodrugs of proton pump inhibitors |
| 09/09/2005 | CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 09/09/2005 | CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 09/08/2005 | US20050197398 mixture of isoleucine, leucine, valine, and alanine, used for treating liver disorders such as hepatitis, cirrhosis or liver cancer |
| 09/08/2005 | US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 09/08/2005 | US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc. |
| 09/08/2005 | US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs |
| 09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/08/2005 | US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/08/2005 | US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species |
| 09/08/2005 | US20050197328 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 09/08/2005 | US20050197299 Peptidomimetic protease inhibitors |
| 09/08/2005 | US20050196793 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers |
| 09/08/2005 | US20050196443 Pulsatile release compositions and methods for enhanced intestinal drug absorption |
| 09/08/2005 | US20050196428 Dilute aqueous solution containing epidermal growth factor in gel |
| 09/08/2005 | US20050196374 Defecation deodorant |
| 09/07/2005 | EP1571214A2 Immunogenic detoxified mutant toxin |
| 09/07/2005 | EP1571213A1 Bifidobacterium longum AR81 (KCCM-10492) enabling inhibition of rotavirus and active protein separated therefrom |
| 09/07/2005 | EP1571155A1 Peptides and medicinal compositions containing the same |
| 09/07/2005 | EP1571147A2 Pyrazole analogs acting on cannabinoid receptors |
| 09/07/2005 | EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists |
| 09/07/2005 | EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/07/2005 | EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor |
| 09/07/2005 | EP1570848A1 Treating postmenopausal women using ultra-low doses of estrogen |
| 09/07/2005 | EP1569904A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 09/07/2005 | EP1569723A2 Nucleotide based medicament and method of use for treatment of conditions in humans |
| 09/07/2005 | EP1569692A2 Betaine and salicylic acid compositions |
| 09/07/2005 | EP1569652A2 N sp 4 /sp-acylcytosine nucleosides for treatment of viral iinfections |
| 09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 09/07/2005 | EP1569528A1 Methods of using a beverage composition |
| 09/07/2005 | EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 09/07/2005 | EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 09/07/2005 | EP1458717B1 Aroyl pyridinones |
| 09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/07/2005 | EP1399434B1 Novel indole derivatives |
| 09/07/2005 | EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 09/07/2005 | EP1349850B1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 09/07/2005 | EP1192132B1 Serine protease inhibitors |
| 09/07/2005 | EP1188747B1 Phenoxypropylamine compounds |
| 09/07/2005 | EP1165087B1 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 09/07/2005 | EP1037634B1 Oral administration form comprising a proton pump inhibitor (e.g.pantoprazole) |
| 09/07/2005 | CN1665934A GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1, 4)-N-acetylglucosaminyltransferase III) expression in plants |
| 09/07/2005 | CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
| 09/07/2005 | CN1665920A Liver engrafting cells, assays, and uses thereof |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 09/07/2005 | CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/07/2005 | CN1665823A Process for preparing 1, 2, 3, 9-tetrahydro-9-methyl-3-[2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
| 09/07/2005 | CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |